In 1979, convinced that many useful therapeutic products were abandoned before reaching their full potential, Dr Rolland-Yves Mauvernay founded the Swiss-based Debiopharm Group™. More than 30 years later, he is still driven by the passion to discover innovative molecules for the treatment of serious medical conditions.
Starting with two people, himself and his secretary, Dr Mauvernay now heads a group of 300 employees with about 400 external consultants. Dr Mauvernay is fully committed to today's group activities, while planning, together with Mr Thierry Mauvernay, Executive Vice President, Debiopharm Group's future to ensure long-term continuity.
A key management principle in the Company, is "know what you don't know and know where to find the expertise needed". Another principle is to know when to stop a development and to understand what one can learn from the interruption of a drug development. What eventually matters is to be persistent, to develop intelligent collaborations and to have a vision of what the future can hold.
More importantly, relationships between people and the quality of Debiopharm Group's collaborators have contributed most to pave the way to the group's success.
The two words that best describe the strength and energy of Debiopharm Group™ are: collective intelligence.
